{"id":"https://openalex.org/W20726118","doi":null,"title":"Buspirone, a novel nonbenzodiazepine anxiolytic.","display_name":"Buspirone, a novel nonbenzodiazepine anxiolytic.","publication_year":1984,"publication_date":"1984-11-01","ids":{"openalex":"https://openalex.org/W20726118","mag":"20726118","pmid":"https://pubmed.ncbi.nlm.nih.gov/6150781"},"language":"en","primary_location":{"id":"pmid:6150781","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6150781","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053001196","display_name":"K. V. Kastenholz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K V Kastenholz","raw_affiliation_strings":["University of Texas at Austin#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas at Austin#TAB#","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039235704","display_name":"M. Lynn Crismon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M L Crismon","raw_affiliation_strings":["Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5498,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.83025946,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"3","issue":"6","first_page":"600","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.6654999852180481,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.6654999852180481,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.08229999989271164,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0689999982714653,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.8880000114440918},{"id":"https://openalex.org/keywords/non-benzodiazepine-anxiolytics","display_name":"non-benzodiazepine anxiolytics","score":0.9520000219345093},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7319999933242798},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6340000033378601},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.9669449329376221},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7692210674285889},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7081758975982666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5927388668060303},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.5849742889404297},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5203306674957275},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.517379879951477},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.4180680215358734},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35928207635879517},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21833407878875732},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.16958901286125183},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.12828025221824646},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.08172506093978882},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06436768174171448}],"mesh":[{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005569","descriptor_name":"Formularies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:6150781","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6150781","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},{"id":"mag:20726118","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6150781","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1985162996","https://openalex.org/W1979163954","https://openalex.org/W2160495932","https://openalex.org/W2004646920","https://openalex.org/W2077219697","https://openalex.org/W2154085133","https://openalex.org/W2040193853","https://openalex.org/W1585244363","https://openalex.org/W2062988293","https://openalex.org/W2064287148","https://openalex.org/W2068149425","https://openalex.org/W2161648401","https://openalex.org/W2671320","https://openalex.org/W2048625278","https://openalex.org/W145917430","https://openalex.org/W2433357274","https://openalex.org/W1987470348","https://openalex.org/W2127865735","https://openalex.org/W1545286379","https://openalex.org/W2171977427","https://openalex.org/W2020837045","https://openalex.org/W2040613067","https://openalex.org/W1506021195","https://openalex.org/W2062602045","https://openalex.org/W1991241006","https://openalex.org/W1766484097","https://openalex.org/W2066531579","https://openalex.org/W2123612204"],"related_works":["https://openalex.org/W2022276674","https://openalex.org/W7073804080","https://openalex.org/W2111382968","https://openalex.org/W1567613111","https://openalex.org/W2102159981","https://openalex.org/W2412762247","https://openalex.org/W2432179198","https://openalex.org/W1972052441","https://openalex.org/W1972777490","https://openalex.org/W3123979629"],"abstract_inverted_index":{"The":[0,27,118,204],"chemistry,":[1],"pharmacology,":[2],"pharmacokinetics,":[3],"clinical":[4],"efficacy,":[5],"adverse":[6,165],"effects,":[7],"dosage,":[8],"administration,":[9],"and":[10,55,85,139,141,158,172],"availability":[11],"of":[12,30,82,89,110,120,149,161,221],"buspirone":[13],"hydrochloride,":[14],"a":[15,60],"novel":[16],"nonbenzodiazepine":[17],"anxiolytic,":[18],"are":[19,167],"reviewed.":[20],"Buspirone":[21,67,129,152,180,212],"hydrochloride":[22,213],"is":[23,34,68,99,103,127,209,214,226],"an":[24,111,215],"azaspirodecanedione":[25],"anxiolytic.":[26],"exact":[28],"mechanism":[29],"its":[31,121,124],"anxiolytic":[32,65,125],"action":[33],"unknown.":[35,128],"It":[36,51,102,196],"does":[37,181],"not":[38,182],"appear":[39],"to":[40,78,123,133,198],"influence":[41],"the":[42,48,80,87,93,147,154,162,175,219,229],"benzodiazepine-gamma-aminobutyric":[43],"acid-chloride":[44],"ionophore":[45],"complex":[46],"as":[47,59,115,135,137,174],"benzodiazepines":[49],"do.":[50],"antagonizes":[52],"striatal-dopamine":[53],"autoreceptors,":[54],"it":[56],"may":[57],"act":[58],"midbrain":[61],"modulator":[62],"exerting":[63],"selective":[64],"activity.":[66],"rapidly":[69],"absorbed":[70],"after":[71],"oral":[72],"administration.":[73],"Administration":[74],"with":[75,106,169,187,228],"food":[76],"appears":[77,197],"slow":[79],"rate":[81],"drug":[83,91,217],"absorption":[84],"increase":[86],"amount":[88],"unchanged":[90,116],"reaching":[92],"systemic":[94],"circulation.":[95],"Buspirone's":[96],"elimination":[97],"half-life":[98],"2.5-3":[100],"hours.":[101],"extensively":[104],"metabolized,":[105],"less":[107],"than":[108,144],"1%":[109],"administered":[112],"dose":[113,208],"excreted":[114],"drug.":[117],"contribution":[119],"metabolites":[122],"effects":[126,160,166],"has":[130],"been":[131],"shown":[132],"be":[134],"effective":[136,143,216],"diazepam":[138],"clorazepate":[140],"more":[142],"placebo":[145],"in":[146,218],"treatment":[148,220],"generalized":[150,222],"anxiety.":[151],"lacks":[153],"sedative,":[155],"muscle":[156],"relaxant,":[157],"anticonvulsive":[159],"benzodiazepines.":[163],"Its":[164],"minimal,":[168],"dizziness,":[170],"nervousness,":[171],"headaches":[173],"most":[176],"common":[177],"side":[178],"effects.":[179],"impair":[183],"driving":[184],"skills,":[185],"interact":[186],"alcohol":[188],"or":[189,192],"concomitant":[190],"medications,":[191],"produce":[193],"physiologic":[194],"dependence.":[195],"have":[199],"little":[200],"potential":[201],"for":[202],"abuse.":[203],"average":[205],"daily":[206],"adult":[207],"15-20":[210],"mg.":[211],"anxiety":[223],"disorder":[224],"that":[225],"comparable":[227],"conventional":[230],"benzodiazepine":[231],"anxiolytics.":[232]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}